These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [GenoType MTBDR plus 1.0® for the detection of cross-resistance between isoniazide and ethionamide in isolates of multidrug-resistant Mycobacterium tuberculosis]. Rueda J; Realpe T; Mejía G; Zapata E; Robledo J Biomedica; 2015; 35(4):541-8. PubMed ID: 26844443 [TBL] [Abstract][Full Text] [Related]
24. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates from Xi'an, China. Zhou A; Nawaz M; Duan Y; Moore JE; Millar BC; Xu J; Yao Y Microb Drug Resist; 2011 Jun; 17(2):275-81. PubMed ID: 21388297 [TBL] [Abstract][Full Text] [Related]
26. [Defining of gene mutations and minimal inhibitory concentrations in isoniazid resistant Mycobacterium tuberculosis isolates]. Yıldırım E; Uzun M Mikrobiyol Bul; 2017 Oct; 51(4):305-316. PubMed ID: 29153061 [TBL] [Abstract][Full Text] [Related]
27. Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic. Isakova J; Sovkhozova N; Vinnikov D; Goncharova Z; Talaibekova E; Aldasheva N; Aldashev A BMC Microbiol; 2018 Mar; 18(1):22. PubMed ID: 29566660 [TBL] [Abstract][Full Text] [Related]
28. [Characterization of the katG, inhA, ahpC, kasA, and oxyR gene mutations in isoniazid-resistant and susceptible strain of Mycobacterium tuberculosis by automated DNA sequencing]. Chen X; Ma Y; Jin Q; Jiang GL; Li CY; Wang Q Zhonghua Jie He He Hu Xi Za Zhi; 2005 Apr; 28(4):250-3. PubMed ID: 15854436 [TBL] [Abstract][Full Text] [Related]
29. The mabA gene from the inhA operon of Mycobacterium tuberculosis encodes a 3-ketoacyl reductase that fails to confer isoniazid resistance. Banerjee A; Sugantino M; Sacchettini JC; Jacobs WR Microbiology (Reading); 1998 Oct; 144 ( Pt 10)():2697-2704. PubMed ID: 9802011 [TBL] [Abstract][Full Text] [Related]
30. Correlating genetic mutations with isoniazid phenotypic levels of resistance in Mycobacterium tuberculosis isolates from patients with drug-resistant tuberculosis in a high burden setting. Pinhata JMW; Brandao AP; Mendes FF; Rabello MCDS; Ferrazoli L; de Oliveira RS Eur J Clin Microbiol Infect Dis; 2021 Dec; 40(12):2551-2561. PubMed ID: 34297229 [TBL] [Abstract][Full Text] [Related]
31. Genotypic analysis of genes associated with isoniazid and ethionamide resistance in MDR-TB isolates from Thailand. Boonaiam S; Chaiprasert A; Prammananan T; Leechawengwongs M Clin Microbiol Infect; 2010 Apr; 16(4):396-9. PubMed ID: 19486070 [TBL] [Abstract][Full Text] [Related]
32. Molecular analysis of isoniazid resistance in Mycobacterium tuberculosis isolates recovered from South Korea. Kim SY; Park YJ; Kim WI; Lee SH; Ludgerus Chang C; Kang SJ; Kang CS Diagn Microbiol Infect Dis; 2003 Nov; 47(3):497-502. PubMed ID: 14596968 [TBL] [Abstract][Full Text] [Related]
33. Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Rouse DA; Li Z; Bai GH; Morris SL Antimicrob Agents Chemother; 1995 Nov; 39(11):2472-7. PubMed ID: 8585728 [TBL] [Abstract][Full Text] [Related]
34. Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa. Kiepiela P; Bishop KS; Smith AN; Roux L; York DF Tuber Lung Dis; 2000; 80(1):47-56. PubMed ID: 10897383 [TBL] [Abstract][Full Text] [Related]
35. [Cross-resistance between isoniazid and ethionamide and its strong association with mutation C-15T in Mycobacterium tuberculosis isolates from Peru]. Sandoval R; Monteghirfo M; Salazar O; Galarza M Rev Argent Microbiol; 2020; 52(1):36-42. PubMed ID: 31255368 [TBL] [Abstract][Full Text] [Related]
36. Genotypic analysis of isoniazid and rifampin resistance in drug-resistant clinical Mycobacterium tuberculosis complex isolates in southern Turkey. Aslan G; Tezcan S; Serin MS; Emekdas G Jpn J Infect Dis; 2008 Jul; 61(4):255-60. PubMed ID: 18653964 [TBL] [Abstract][Full Text] [Related]
37. Contribution of dfrA and inhA mutations to the detection of isoniazid-resistant Mycobacterium tuberculosis isolates. Ho YM; Sun YJ; Wong SY; Lee AS Antimicrob Agents Chemother; 2009 Sep; 53(9):4010-2. PubMed ID: 19581462 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of inhA gene and catalase-peroxidase gene among isoniazid-sensitive and resistant Mycobacterium tuberculosis isolates. O'Brien KL; Dietz HC; Romagnoli M; Eiden J Mol Cell Probes; 1996 Feb; 10(1):1-6. PubMed ID: 8684371 [TBL] [Abstract][Full Text] [Related]
39. Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America. Dalla Costa ER; Ribeiro MO; Silva MS; Arnold LS; Rostirolla DC; Cafrune PI; Espinoza RC; Palaci M; Telles MA; Ritacco V; Suffys PN; Lopes ML; Campelo CL; Miranda SS; Kremer K; da Silva PE; Fonseca Lde S; Ho JL; Kritski AL; Rossetti ML BMC Microbiol; 2009 Feb; 9():39. PubMed ID: 19228426 [TBL] [Abstract][Full Text] [Related]
40. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. Musser JM; Kapur V; Williams DL; Kreiswirth BN; van Soolingen D; van Embden JD J Infect Dis; 1996 Jan; 173(1):196-202. PubMed ID: 8537659 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]